Information Technology and Logistic Considerations
The core products with which GHPC will immediately go to market are specific formulas based on a nutrient delivery technology. Branched chain amino-acid nutrient substrate delivery enters into a realm of extremely complex metabolic dynamics. GHPC will best leverage product improvement, ongoing research and enhanced profitability by suitably using, and in the long run acquiring, robust computational assets in order to deal with the data load involved in research, modeling and refinement. This path, an emerging necessity, is already recognized and employed regarding genomics and proteomics, which are similarly involved in charting and understanding complex dynamics that only the advent of modern computing techniques and technology renders possible.
GHPC will carefully, and in line with increasing revenue streams, bring to bear the most powerful and effective information technology products relevant to data acquisition, data management, data modeling and data warehousing, including, but not limited to, parallel and distributed computing in efforts to aggregate, correlate and otherwise assimilate clinical, laboratory and academic datasets.
Modern information technology and distributed computing is a major key asset in ascertaining the framework for optimized nutritional intervention in various, clinically defined situations. Metabolic pathways are subject to extremely complex interactions and transformations of amino acids and proteins during phases of metabolism and as nutrients enter the blood mediated by the gut.
Advances in parallel, distributed computing platforms and database systems allow these interactions and patterns to be mapped out and determined with a new level of specificity and exactness in many nutritional support and intervention categories. For example, through modeling and medical database analyses, Myogence and Atheromine can be further refined and customized for specific populations where nutrition is a premium including: sedentary baby boomers, cyclists, dialysis patients, a growing diabetic population, and women entering menopause to identify a few. But more importantly, aggregating and modeling data on specific nutritional challenge domains will also lead to entirely new product offerings based on the more fundamental and tailored nutritional approach.
This approach will allow GHPC to best leverage its advantage alongside an emerging medical recognition of the need to move beyond a "one size fits all" mindset. Meeting exacting individual requirements with formulations attuned to precise needs, a key to avoiding mistakes and truly optimizing treatment, will save thousands more lives.
GHPC can see substantial profit potential in the resulting dataset product, i.e., both the computing and database dimensions closely tied to the direction above. The knowledge base acquired through product development and the aggregation of metabolic process data necessary to build ever more informative, yet totally discrete, individual treatment profiles will yield definitions valuable to other major healthcare entities, be they corporate, governmental or humanitarian. The definition of a "metabolic pathway" is eligible for U.S. Patent protection. GHPC will be poised to profit from various new applications of the complex datasets and models its product development will engender - and GHPC will remain keenly focused on both the significance of such assets and how to best leverage them in terms of responsible corporate interest.
Additionally, depending on the results of clinical trials and/or the addition of new biotech acquisitions specifically useful in African chronic disease treatment, GHPC will carefully consider extending such technological assets into the realm of treatment delivery and logistics. The demands of Africa and other resource limited settings beg for new approaches to tracking, auditing, reporting and data collection, as well as enhancing practical and humane treatment delivery.
Substantial global funding entities, actively seek solutions to bottlenecks created by corruption, as well as various infrastructural challenges. Many new approaches can only now be seriously entertained by virtue of miniaturized, dependable computer technology and database systems - along with coordination with remote medical professionals to handle various treatment complications in an affordable, practical manner. GHPC will assess possibilities on this front, either in developing proprietary systems or in partnership with other entities, with a firm view to corporate well being and in light of decades of experience dealing with the exigencies of African logistical demands.